BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)

Clinical trial NCT05156710 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05156710
Sponsor: Sanofi
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Transplant Rejection

Start date: 2022-06-09
Primary completion: 2025-10-21
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.